Seminars in Pediatric Surgery
Volume 16, Issue 2 , Pages 126-133 , May 2007

Pulmonary hypertension in congenital diaphragmatic hernia

  • Hadi Mohseni-Bod, MD
    • ,
  • Desmond Bohn, MB

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Desmond Bohn, MB, The Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.

References 

  1. Rottier R, Tibboel D. Fetal lung and diaphragm development in congenital diaphragmatic hernia. Semin Perinatol. 2005;29:86–93
  2. Beals DA, Schloo BL, Vacanti JP, et al. Pulmonary growth and remodeling in infants with high-risk congenital diaphragmatic hernia. J Pediatr Surg. 1992;27:997–1001
  3. deMello DE, Sawyer D, Galvin N, et al. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol. 1997;16:568–581
  4. Roubliova X, Verbeken E, Wu J, et al. Pulmonary vascular morphology in a fetal rabbit model for congenital diaphragmatic hernia. J Pediatr Surg. 2004;39:1066–1072
  5. Lipsett J, Cool JC, Runciman SI, et al. Morphometric analysis of preterm fetal pulmonary development in the sheep model of congenital diaphragmatic hernia. Pediatr Dev Pathol. 2000;3:17–28
  6. Sokol J, Bohn D, Lacro RV, et al. Fetal pulmonary artery diameters and their association with lung hypoplasia and postnatal outcome in congenital diaphragmatic hernia. Am J Obstet Gynecol. 2002;186:1085–1090
  7. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000;279:L600–L607
  8. Grover TR, Parker TA, Balasubramaniam V, et al. Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2005;288:L648–L654
  9. Sciaky-Tamir Y, Cohen SM, Hochner-Celnikier D, et al. Three-dimensional power Doppler (3DPD) ultrasound in the diagnosis and follow-up of fetal vascular anomalies. Am J Obstet Gynecol. 2006;194:274–281
  10. Kasprian G, Balassy C, Brugger PC, et al. MRI of normal and pathological fetal lung development. Eur J Radiol. 2006;57:261–270
  11. Rudolph AM, Heymann MA. Circulatory changes during growth in the fetal lamb. Circ Res. 1970;26:289–299
  12. Levy M, Maurey C, nh-Xuan AT, et al. Developmental expression of vasoactive and growth factors in human lung (Role in pulmonary vascular resistance adaptation at birth). Pediatr Res. 2005;57:21R–25R
  13. Hislop A. Developmental biology of the pulmonary circulation. Paediatr Respir Rev. 2005;6:35–43
  14. Vukcevic Z, Coppola CP, Hults C, et al. Nitrovasodilator responses in pulmonary arterioles from rats with nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg. 2005;40:1706–1711
  15. de LP, de Buys-Roessingh A, Ferkdadji L, et al. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol. 2005;205:112–118
  16. Shehata SM, Sharma HS, Mooi WJ, et al. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase. Cell Biochem Biophys. 2006;44:147–155
  17. Chang R, Andreoli S, Ng YS, et al. VEGF expression is downregulated in nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg. 2004;39:825–828
  18. Sakai M, Unemoto K, Solari V, et al. Decreased expression of voltage-gated K+ channels in pulmonary artery smooth muscles cells in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatr Surg Int. 2004;20:192–196
  19. Solari V, Puri P. Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. J Pediatr Surg. 2004;39:302–306
  20. Newell MA, Au-Fliegner M, Coppola CP, et al. Hypoxic pulmonary vasoconstriction is impaired in rats with nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg. 1998;33:1358–1362
  21. Masumoto K, de Rooij JD, Suita S, et al. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls. Histopathology. 2006;48:588–595
  22. Nakayama DK, Motoyama EK, Evans R, et al. Relation between arterial hypoxemia and plasma eicosanoids in neonates with congenital diaphragmatic hernia. J Surg Res. 1992;53:615–620
  23. Jesudason EC, Smith NP, Connell MG, et al. Peristalsis of airway smooth muscle is developmentally regulated and uncoupled from hypoplastic lung growth. Am J Physiol Lung Cell Mol Physiol. 2006;291:L559–L565
  24. Dillon PW, Cilley RE, Mauger D, et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg. 2004;39:307–312
  25. Suda K, Bigras JL, Bohn D, et al. Echocardiographic predictors of outcome in newborns with congenital diaphragmatic hernia. Pediatrics. 2000;105:1106–1109
  26. Sokol J, Shimizu N, Bohn D, et al. Fetal pulmonary artery diameter measurements as a predictor of morbidity in antenatally diagnosed congenital diaphragmatic hernia: a prospective study. Am J Obstet Gynecol. 2006;
  27. Sokol J, Bohn D, Lacro RV, et al. Fetal pulmonary artery diameters and their association with lung hypoplasia and postnatal outcome in congenital diaphragmatic hernia. Am J Obstet Gynecol. 2002;186:1085–1090
  28. Casaccia G, Crescenzi F, Dotta A, et al. Birth weight and McGoon Index predict mortality in newborn infants with congenital diaphragmatic hernia. J Pediatr Surg. 2006;41:25–28
  29. Drummond WH, Gregory GA, Heymann MA, et al. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr. 1981;98:603–611
  30. Wung JT, James LS, Kilchevsky E, et al. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics. 1985;76:488–494
  31. Boloker J, Bateman DA, Wung JT, et al. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair. J Pediatr Surg. 2002;37:357–366
  32. Wung JT, Sahni R, Moffitt ST, et al. Congenital diaphragmatic hernia: survival treated with very delayed surgery, spontaneous respiration, and no chest tube. J Pediatr Surg. 1995;30:406–409
  33. Bohn D. Congenital diaphragmatic hernia. Am J Respir Crit Care Med. 2002;166:911–915
  34. Buss M, Williams G, Dilley A, et al. Prevention of heart failure in the management of congenital diaphragmatic hernia by maintaining ductal patency (A case report). J Pediatr Surg. 2006;41:e9–e11
  35. Boloker J, Bateman DA, Wung JT, et al. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair. J Pediatr Surg. 2002;37:357–366
  36. Inamura N, Kubota A, Nakajima T, et al. A proposal of new therapeutic strategy for antenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 2005;40:1315–1319
  37. Tanabe M, Yoshida H, Iwai J, et al. Doppler flow patterns through the ductus arteriosus in patients with congenital diaphragmatic hernia. Eur J Pediatr Surg. 2000;10:92–95
  38. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics. 1997;99:838–845
  39. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597–604
  40. Greenough A. Inhaled nitric oxide in the neonatal period. Expert Opin Investig Drugs. 2000;9:1601–1609
  41. Koh TH, Gandini D, Vijayakumar P. The neonatal inhaled nitric oxide study. J Pediatr. 2001;138:300
  42. Daniele DL, Zecca E, Vento G, et al. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia. Paediatr Anaesth. 2006;16:597–598
  43. Keller RL, Hamrick SE, Kitterman JA, et al. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia. Pediatr Crit Care Med. 2004;5:184–187
  44. Harris K. Extralobar sequestration with congenital diaphragmatic hernia: a complicated case study. Neonatal Netw. 2004;23:7–24
  45. Fraisse A, Habib G. [Treatment of pulmonary arterial hypertension in children]. Arch Pediatr. 2004;11:945–950
  46. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol. 2004;38:2–22
  47. Ivy DD, Kinsella JP, Ziegler JW, et al. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 1998;115:875–882
  48. Thebaud B, Saizou C, Farnoux C, et al. Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. Intensive Care Med. 1999;25:300–303
  49. Ziegler JW, Ivy DD, Wiggins JW, et al. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998;158:1388–1395
  50. Buysse C, Fonteyne C, Dessy H, et al. The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg. 2001;36:1864–1865
  51. Kinsella JP, Parker TA, Ivy DD, et al. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr. 2003;142:397–401
  52. Barst RJ, Ivy D, Dingemanse J, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther. 2003;73:372–382
  53. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol. 2004;38:2–22
  54. Widlitz A, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21:155–176
  55. Barst RJ. Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatr Clin North Am. 1999;46:331–345
  56. Murali S. Pulmonary arterial hypertension. Curr Opin Crit Care. 2006;12:228–234
  57. Berman RE, Barst RJ. Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment. Treat Respir Med. 2006;5:117–127
  58. Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol. 2006;47:2049–2056
  59. Paidas CN, Dudgeon DL, Haller JA, et al. Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg. 1988;23:1154–1160
  60. Morgan JM, McCormack DG, Griffiths MJ, et al. Adenosine as a vasodilator in primary pulmonary hypertension. Circulation. 1991;84:1145–1149
  61. Fullerton DA, Jaggers J, Jones SD, et al. Adenosine for refractory pulmonary hypertension. Ann Thorac Surg. 1996;62:874–877
  62. Fullerton DA, Jones SD, Grover FL, et al. Adenosine effectively controls pulmonary hypertension after cardiac operations. Ann Thorac Surg. 1996;61:1118–1123
  63. Patole S, Lee J, Whitehall J. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension. Indian Pediatr. 1999;36:307–310
  64. Ng C, Franklin O, Vaidya M, et al. Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med. 2004;5:10–13
  65. Motti A, Tissot C, Rimensberger PC, et al. Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy. Pediatr Crit Care Med. 2006;7:380–382
  66. Michaels AD, Chatterjee K, De MT. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. J Card Fail. 2005;11:425–431
  67. Kurian DC, Wagner IJ, Klapholz M. Nesiritide in pulmonary hypertension. Chest. 2004;126:302–305
  68. Bhat G, Costea A. Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient. ASAIO J. 2003;49:608–610
  69. DeAnda A, Cahill JL, Bernstein D, et al. Elective transplant pneumonectomy. J Pediatr Surg. 1998;33:655–656
  70. Van Meurs KP, Rhine WD, Benitz WE, et al. Lobar lung transplantation as a treatment for congenital diaphragmatic hernia. J Pediatr Surg. 1994;29:1557–1560
  71. Murali S. Pulmonary arterial hypertension. Curr Opin Crit Care. 2006;12:228–234
  72. Said SI. Mediators and modulators of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2006;291:L547–L558
  73. Siebert JR, Haas JE, Beckwith JB. Left ventricular hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg. 1984;19:567–571
  74. Sharland GK, Lockhart SM, Heward AJ, et al. Prognosis in fetal diaphragmatic hernia. Am J Obstet Gynecol. 1992;166:9–13
  75. Sutton MS, Groves A, MacNeill A, et al. Assessment of changes in blood flow through the lungs and foramen ovale in the normal human fetus with gestational age: a prospective Doppler echocardiographic study. Br Heart J. 1994;71:232–237
  76. Rasanen J, Wood DC, Weiner S, et al. Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy. Circulation. 1996;94:1068–1073
  77. Rudolph AM, Heymann MA. Circulatory changes during growth in the fetal lamb. Circ Res. 1970;26:289–299
  78. Momma K, Ando M, Mori Y, et al. Hypoplasia of the lung and heart in fetal rats with diaphragmatic hernia. Fetal Diagn Ther. 1992;7:46–52
  79. Karamanoukian HL, Glick PL, Wilcox DT, et al. Pathophysiology of congenital diaphragmatic hernia (XI: Anatomic and biochemical characterization of the heart in the fetal lamb CDH model). J Pediatr Surg. 1995;30:925–928
  80. Guarino N, Shima H, Puri P. Structural immaturity of the heart in congenital diaphragmatic hernia in rats. J Pediatr Surg. 2001;36:770–773
  81. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol. 2005;29:123–128
  82. Inamura N, Kubota A, Nakajima T, et al. A proposal of new therapeutic strategy for antenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 2005;40:1315–1319
  83. Iocono JA, Cilley RE, Mauger DT, et al. Postnatal pulmonary hypertension after repair of congenital diaphragmatic hernia: predicting risk and outcome. J Pediatr Surg. 1999;34:349–353
  84. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol. 2005;29:123–128
  85. Taira Y, Yamataka T, Miyazaki E, et al. Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia. Pediatr Surg Int. 1998;14:30–35
  86. Taira Y, Yamataka T, Miyazaki E, et al. Adventitial changes in pulmonary vasculature in congenital diaphragmatic hernia complicated by pulmonary hypertension. J Pediatr Surg. 1998;33:382–387
  87. Jeandot R, Lambert B, Brendel AJ, et al. Lung ventilation and perfusion scintigraphy in the follow up of repaired congenital diaphragmatic hernia. Eur J Nucl Med. 1989;15:591–596
  88. Nagaya M, Akatsuka H, Kato J, et al. Development in lung function of the affected side after repair of congenital diaphragmatic hernia. J Pediatr Surg. 1996;31:349–356
  89. Arena F, Baldari S, Centorrino A, et al. Mid- and long-term effects on pulmonary perfusion, anatomy and diaphragmatic motility in survivors of congenital diaphragmatic hernia. Pediatr Surg Int. 2005;21:954–959
  90. Okuyama H, Kubota A, Kawahara H, et al. Correlation between lung scintigraphy and long-term outcome in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol. 2006;41:882–886
  91. Kamata S, Usui N, Kamiyama M, et al. Long-term follow-up of patients with high-risk congenital diaphragmatic hernia. J Pediatr Surg. 2005;40:1833–1838
  92. Trachsel D, Selvadurai H, Bohn D, et al. Long-term pulmonary morbidity in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol. 2005;39:433–439
  93. Trachsel D, Selvadurai H, Adatia I, et al. Resting and exercise cardiorespiratory function in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol. 2006;41:522–529

PII: S1055-8586(07)00009-1

doi: 10.1053/j.sempedsurg.2007.01.008

Seminars in Pediatric Surgery
Volume 16, Issue 2 , Pages 126-133 , May 2007

Article Tools